Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (651-660 of 692) with videos related to

Pageof 70
Sort By:
European Urology|March 21, 2014
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302)Dana E Rathkopf, Matthew R Smith, Johann S de Bono, et al.
JAMA Oncology|December 28, 2018
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Michael L Cheng, Joshua Armenia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Nature|July 12, 2019
Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Nature|December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted TherapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Journal of the National Cancer Institute|July 30, 2020
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic EfficacyKenneth L Pitter, Dana L Casey, Yue C Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
JAMA Network Open|January 18, 2023
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 InfectionStephanie A Richard, Simon D Pollett, Anthony C Fries, et al.
Pageof 70

Showing results (651-660 of 692) with videos related to

Sort By:
Pageof 70
European Urology|March 21, 2014
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302)Dana E Rathkopf, Matthew R Smith, Johann S de Bono, et al.
JAMA Oncology|December 28, 2018
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint BlockadeWassim Abida, Michael L Cheng, Joshua Armenia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Nature|July 12, 2019
Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Nature|December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Cancer Research|January 24, 2012
ARN-509: a novel antiandrogen for prostate cancer treatmentNicola J Clegg, John Wongvipat, James D Joseph, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted TherapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Journal of the National Cancer Institute|July 30, 2020
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic EfficacyKenneth L Pitter, Dana L Casey, Yue C Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
JAMA Network Open|January 18, 2023
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 InfectionStephanie A Richard, Simon D Pollett, Anthony C Fries, et al.
Pageof 70